The human genome is peppered with regions of repetitive DNA—hypervariable regions
consisting of a short DNA sequence repeated in tandem. These regions are polymorphic in
that the sequence varies in the number of copies of the repeat unit. The number of
repeat units is indicated by the allele designation. For example, 14 copies of the
repeat unit would be referred to as allele 14. In the early 1980s, these regions were
investigated as informative markers to map the human genome (Wyman and White, 1980;
Jeffreys et al., 1985a), but one of the founding fathers of DNA
typing, Alec Jeffreys, quickly realized that these markers could be employed for
DNA-based human identification (Jeffreys et al., 1985b).
In the early days of DNA-based identification, the hypervariable regions of
interest were variable number tandem repeat (VNTR) loci, which had a high level of
heterozygosity and were relatively large in size (300–10,000bp) (Nakamura
et al., 1987; Budowle et al., 1991). VNTRs were
analyzed using restriction fragment length polymorphism (RFLP), where
high-molecular-weight target DNA is digested with a restriction enzyme that has
recognition sites at both ends of the hypervariable region. The size of the DNA
fragment resulting from the restriction enzyme digestion is dictated by the number of
repeat elements. These fragments are separated by size using agarose or
polyacrylamide gel electrophoresis and detected using a labeled VNTR probe. Analysis
of multiple VNTR loci results in a unique pattern of DNA fragments on the gel. The
patterns generated from a DNA sample of unknown origin and DNA of known origin are
compared. Matching patterns indicate that the sources of the unknown and known DNA
samples are likely the same. RFLP analysis of VNTR loci works well to resolve
immigration and paternity disputes and for other applications where large amounts of
intact DNA can be collected. However, RFLP is not ideally suited to forensic
investigations because microgram amounts of high-molecular-weight DNA are
required.Thus, VNTR analysis is limited to investigations where large amounts of DNA
are recovered.
Many samples recovered from crime scenes yield only nanogram or picogram amounts
of DNA that is sometimes degraded, and thus not suitable for VNTR analysis. To
overcome this limitation, scientists harnessed the polymerase
chain reaction (PCR; Saiki et al., 1985) to amplify
shorter hypervariable regions known as short tandem repeat (STR) loci. STR loci
consist of short, repetitive sequence elements 3–7 base pairs in length (Edwards
et al., 1991a; Edwards et al., 1991b;
Edwards et al., 1992; Warne et al., 1991).
By using PCR, minute amounts of DNA can be amplified and analyzed and, because STR
loci are much shorter than VNTR loci, degraded DNA can be successfully analyzed. This
amplified fragment length polymorphism (AmpFLP) technique allows generation of full
DNA profiles from trace biological samples, such as blood spatter, fingerprints,
saliva, semen and other body fluids, bone, tissue and hair collected during forensic
casework and missing persons investigations. In addition, PCR-based STR analysis is
higher-throughput so that more samples can be analyzed in less time. For these
reasons, STR analysis has replaced VNTR analysis for human identification purposes.
The human genome is organized as 23 pairs of chromosomes: the X and Y sex
chromosomes and the remaining autosomal chromosome pairs, numbered 1 through 22. STR
loci exist on both autosomes and sex chromosomes. Ideally STR loci for forensic use
are physically separated enough so that they are inherited independently of each
other (i.e., not genetically linked). Sequences on different autosome pairs are not
usually linked due to independent assortment of chromosomes during meiosis. Females
possess two X chromosomes, which can recombine during meiosis. However, X-STR loci
can show linkage disequilibrium (Tillmar, et al., 2008) and tend
to fall within four linkage groups. In males, neither X-STR nor Y-STR loci are linked
because these chromosomes do not pair during meiosis and cannot undergo
recombination, except for a small pseudoautosomal region of the X-Y pair (Gusmão and
Carracedo, 2003). This difference in genetic inheritance becomes important during
data analysis. Data generated using autosomal STR loci and X- and Y-STR loci cannot
be used in the same way (see the Data Analysis
section). A more detailed discussion of STR analysis is provided below.
A single nucleotide polymorphism (SNP) is a variation in DNA sequence at a single
base. SNPs can be used for human identification, although studies suggest that 50–80
loci are required to achieve the same discrimination level of 16 STR loci [Gill,
2001]. There are nearly 6 million SNPs in numerous online databases, but only a
fraction of these are useful for human identification because some are less
polymorphic than others or difficult to amplify in multiplex PCR. The requirement for
small amplicon sizes (60–120 bp) and robust multiplex PCR with minimal nonspecific
amplification further reduces the number of SNPs suitable for forensic applications.
Appropriate criteria are being identified to select the most useful and robust loci
and develop a core panel of SNPs for optimum discrimination in forensic applications
(Phillips, 2003).
Analysis of large numbers of SNPs by direct sequencing is expensive and
time-consuming, so in addition to multiplex PCR, SNPs are typed by minisequencing,
which is simple, non-radioactive and easily multiplexed. Minisequencing involves
amplification of an unlabeled PCR product that spans the SNP, then interrogation
using a probe that anneals immediately adjacent to the SNP. This probe is allowed to
hybridize to the PCR product in the presence of labeled dideoxynucleotides (ddNTPs)
and DNA polymerase. The probe is extended at the 3′-end through addition of the ddNTP
that is complementary to the single nucleotide polymorphism. The extended probe is
separated by electrophoresis, and the incorporated ddNTP is detected. Because each
ddNTP is labeled with a different fluor, the color of the peak denotes the SNP
allele. Multiplex SNP analysis is made possible by adding a defined number of
nucleotides to the 5′-end of each probe so that the SNP probes can be resolved
electrophoretically.
While analysis of nuclear DNA provides full STR profiles in many situations,
ancient or degraded samples often yield partial profiles or no profile. In these
cases, analysis of mitochondrial DNA (mtDNA) may provide information where nuclear
DNA analysis cannot. Mitochondria are cellular organelles that provide most of the
energy required for various cellular functions. The number of mitochondria per cell
varies with the cell type, ranging from hundreds to thousands of mitochondria per
cell, and each mitochondrion contains many copies of its own DNA. Thus, mtDNA has a
much higher copy number per cell than nuclear DNA. In addition, human mtDNA is a
circular molecule of 16,569bp (Anderson et al., 1981), and this
circular nature makes mtDNA more resistant to exonucleases. For these reasons, there
is often enough mtDNA, even in degraded samples, for analysis.
Samples well suited to mtDNA analysis include bones, teeth, hair and old or
degraded samples, which often have little high-molecular-weight nuclear DNA. Hair is
a common sample type discovered at crime scenes, but hair presents a problem to
forensic examiners because, as hair is shed, genomic DNA in the root cells undergoes
programmed degradation (Linch, 1998). Also, cells within the hair shaft lose their
nuclei, but not mitochondria, during development. As a result, nuclear DNA analysis
of hair is frequently unsuccessful. Sequence analysis of hypervariable regions within
mtDNA from shed hair shafts offer an alternative, but less discriminating, approach.
mtDNA contains two hypervariable regions that are used for human identification
purposes: the 342bp HVI region and 268bp HVII region. HVI and HVII polymorphisms
arise through random mutation and are inherited through the maternal lineage. Thus,
mtDNA analysis cannot distinguish between people of the same maternal lineage. mtDNA
sequence variations, or haplotypes, are identified by sequencing the HVI and HVII
regions and comparing these sequences to a reference sequence. Any nucleotides that
differ from this standard are noted. However, mtDNA analysis is complicated by the
fact that not all mitochondria within an organism or even a single cell have exactly
the same mtDNA sequence. This heterogeneity, known as heteroplasmy, may be present as
single nucleotide substitutions or variations in the length of the hypervariable
region.
return to top of page
Any biological material is a potential source of DNA for analysis. However, the
success of DNA typing often depends on the quality and nature of the sample. In the
past, DNA-typing efforts focused on samples that had a high probability of providing
relatively large amounts of intact DNA and yielding a full DNA profile. However, trace
evidence samples, which have limited amounts of biological material, are increasingly
common in forensic laboratories due to the sensitive nature of STR typing. DNA profiles
can be successfully generated from trace samples such as fingerprints, saliva and sweat
stains. While success rates for analysis of these trace samples are increasing, some
samples still do not yield adequate DNA amounts for analysis, and even if DNA yields
appear high, the DNA may be degraded to the point where amplification is impossible.
This is often the case when samples are exposed to the environment for long periods of
time. Environmental exposure is not kind to DNA. Many biological samples are ideal
substrates for the growth of bacteria and other microorganisms, which can degrade DNA.
Exposure to ultraviolet light in the form of sunlight can induce pyrimidine dimers,
which can inhibit PCR. Other PCR inhibitors can be introduced by the environment (e.g.,
humic acid in soil), by the substrate on which the sample is deposited (e.g., indigo dye
from denim) or by the sample itself (e.g., hematin from blood samples). The ability to
purify DNA free of these inhibitors can be critical to STR analysis success.
Samples collected during an investigation are often collected on a cotton swab or
other solid support. The first step to purify DNA from these samples involves removing
the biological material from the solid support, typically by soaking the material in an
aqueous buffer. Some samples, such as blood and semen, require a proteinase K digestion
at this step for maximum DNA yield and quality. The solid support is removed by placing
the entire sample, including the solid support, into a spin basket assembly and
centrifuging so that the liquid flows through the spin basket into a collection tube and
the solid support remains in the spin basket. The solid support is discarded, and the
aqueous DNA-containing fraction undergoes subsequent purification steps to remove PCR
inhibitors and other components that may interfere with DNA quantitation and
amplification.
Sample transfer and assembly and disassembly of spin baskets can be tedious and prone
to error when large numbers of samples are processed and individual spin baskets are
used. The Slicprep™ 96 Device (Cat.# V1391) offers a
higher-throughput option that allows simultaneous centrifugation of 96 samples. The
device is designed so that both the digestion or cell lysis step and centrifugation are
performed in the same device. The Slicprep™ 96 Device consists of 3 components: a 2.2ml
96 Deep Well Plate, a 96 Spin Basket and a U-Shaped Collar. In the digestion position,
the 96 Spin Basket is fully inserted into the 96 Deep Well Plate, allowing space for
approximately 165µl of solution below the basket in each well. After the incubation, the
baskets are raised approximately 1cm (the spin position) by inserting the U-Shaped
Collar to create space for an additional 500µl of solution (Figure 14.1). The device is
centrifuged, and the collar and 96 Spin Basket are discarded, leaving the DNA-containing
solution in the 96 Deep Well plate. The 96 Deep Well Plate then can be used for manual
DNA purification or transferred to an automated workstation for DNA purification.
More information on the Slicprep™ 96 Device....
Common DNA purification methods include organic extraction using phenol:chloroform,
Chelex® extraction and the use of a silica magnetic resin.
Phenol:chloroform extraction is considered by many DNA analysts to be the “gold
standard” of DNA isolation methods. However, this method uses hazardous organic
chemicals, is time-consuming, requires multiple centrifugations, may result in
significant loss of material, is not amenable to automation and can introduce
amplification inhibitors. DNA extraction using Chelex® resin
is rapid but does a poor job of removing organic inhibitors. In contrast, magnetic
resin-based DNA purification systems are effective at removing PCR inhibitors, do not
require organic solvents and can be automated to increase throughput.
The DNA IQ™ System uses a silica-based paramagnetic resin to isolate DNA from
liquid samples and samples on solid supports. The DNA IQ™ System will isolate all DNA
types present in a sample, including nuclear and mitochondrial DNA. Two protocols
exist for the manual format, one for database samples and another for forensic casework samples. For samples with abundant DNA, such as buccal
swabs collected as reference samples, the amount of DNA IQ™ Resin used is limiting so
that the resin becomes saturated and any excess DNA is not bound, leading to the
isolation of a consistent amount of DNA from all samples. For casework samples with
limited DNA amounts, the resin is not saturated, and the amount of DNA isolated is
limited only by the amount of starting material.
The DNA IQ™ System allows DNA isolation from a wide variety of sample types,
including blood and blood stains, semen and semen stains, chewing gum, hair, bone,
urine, cigarette butts, buccal swabs and blood card punches.
View a more comprehensive list of sample types
processed using the DNA IQ™ System...
Hair, bone, sperm and tissue masses, including formalin-fixed, paraffin-embedded
tissue, require proteinase K digestion to obtain reliable amounts of DNA. The Tissue
and Hair Extraction Kit (for use with DNA IQ™) (Cat.#
DC6740) includes proteinase K and DTT, which aid in the break up of
tissue, hair and bone samples prior to DNA purification using the DNA IQ™
System.
The paramagnetic DNA IQ™ Resin is amenable to automation, and the DNA IQ™ System
has been automated on a number of robotic platforms. More information about automated
DNA purification can be found below
Additional Resources for DNA IQ™ System
Technical Bulletins and Manuals
TB296
DNA IQ™ System—Small Sample Casework Protocol
TB297
DNA IQ™ System—Database Protocol
TB307
Tissue and Hair Extraction Kit (for use with DNA IQ™) Technical
Bulletin
Promega Publications
GIN021
The DNA IQ™ System on the Tecan Freedom EVO®
100
GIN014
Forensic extraction and isolation of DNA from hair, tissue and
bone
GIN013
DNA IQ™ System "frequently asked questions"
GIN012
DNA IQ™: The intelligent way to purify DNA
AN106
Genomic DNA purification from cigarette butts and buccal swabs using the
DNA IQ™ System
return to top of page
Sexual assault swabs make up a large percentage of samples submitted for DNA
analysis. Processing of these samples involves separating sperm cells, which contain
male DNA, and epithelial cells, which are mostly female-derived so that female DNA will
not obscure the profile of the male DNA contributor. In 1985, Gill et
al. (Gill et al., 1985) developed a method to
selectively enrich for sperm cells in the presence of an excess of epithelial cells. In
the absence of dithiothreitol (DTT), detergent/proteinase K treatment preferentially
lyses epithelial cells, converting the large excess of epithelial cells into soluble
DNA. Sperm are resistant to lysis under these conditions. Proteinase K digestion also
loosens the attachment of sperm to solid supports and reduces the degree of sperm and
epithelial cell clumping, increasing yields and allowing better separation (Tereba
et al., 2004). The proteinase K-digested sample is centrifuged
to efficiently pull sperm out of the cotton fibers, extract the entire volume of
epithelial DNA-containing buffer from the matrix and pellet intact sperm at the bottom
of the tube. The aqueous phase is removed as the epithelial fraction, and the sperm
pellet is washed and recentrifuged to remove any residual epithelial DNA-containing
buffer prior to sperm lysis. Multiple rounds of washes and centrifugations may be
required to obtain a sperm pellet relatively free of epithelial DNA.
One limitation of this traditional method is the inability to efficiently separate
soluble DNA from the cell pellet. In addition, the high number of washes and
centrifugations is laborious and time-consuming and necessitates a delicate balance
between clean separation and loss of sperm. In spite of these issues, this method
remains the preferred method in many forensic laboratories. However, the amount of time
required to process sexual assault samples using this method has resulted in a steady
increase in sample backlogs. Unfortunately, traditional differential extraction methods
to process sexual assault samples are not amenable to automation.
To increase the throughput of differential extraction, Promega has developed the
Differex™ System (Cat.# DC6800). Whereas traditional
differential extraction methods use serial washes and centrifugations to separate sperm
and epithelial cells, the Differex™ System uses a combination of phase separation and
differential centrifugation. This protocol uses only one centrifugation instead of four
or more for traditional methods, and because fewer sperm cells are lost, DNA yields are
higher.
The Differex™ protocol starts by placing the entire proteinase K-digested sample in a
spin basket seated in a tube containing a nonaqueous Separation Solution. Alternatively,
for large numbers of samples, the Slicprep™ 96 Device can be used instead of individual
spin baskets. The Separation Solution is not miscible with water and is more dense than
water but less dense than sperm. During centrifugation, the sperm are pulled from the
solid matrix and form a tight pellet at the bottom of the tube under the Separation
Solution. The soluble DNA remains in the aqueous buffer, which forms a layer on top of
the Separation Solution. The aqueous buffer containing the epithelial DNA is removed,
and the DNA purified using the DNA IQ™ chemistry. The Separation Solution is washed to
eliminate the thin film of epithelial DNA-containing buffer at the interface between the
two layers and any droplets on the side of the tube. Up to half of the Separation
Solution can be removed to eliminate any cell debris that is present at the interface
between the two solutions. After washing, the tube contains the sperm pellet and
remaining Separation Solution. Two or more volumes of DNA IQ™ Lysis Buffer containing
DTT are added to lyse the sperm and solubilize the Separation Solution. The DNA IQ™
Resin is added, and the sperm DNA is purified using the DNA IQ™ chemistry. The Differex™
separation and subsequent DNA purification require as little as 2 hours. An adaptation
of this process for automated differential extraction is described below.
Additional Resources for Differex™ System
Technical Bulletins and Manuals
TBD020
Differex™ System Technical Bulletin
TM331
Differex™ System—For Use With the Differex™ Magnet Technical Manual
Promega Publications
GIN019
Tech Tips: The Differex™ System
GIN018
A new, rapid method to separate sperm and epithelial cells
return to top of page
DNA purification methods cannot differentiate between human DNA and other DNA (e.g.,
bacterial and fungal DNA). Therefore, if the sample is not pristine and you want to
determine the concentration of human genomic DNA present, you will need to use a
human-specific DNA quantitation system. In forensics, the most common systems are based
on real-time PCR and harness fluorescently labeled oligonucleotide probes or primers to
detect and quantitate a PCR product in real time. These systems employ two different
fluorescent reporters and rely on energy transfer from one reporter (the energy donor)
to a second reporter (the energy acceptor) when the reporters are in close proximity.
The second reporter can be a quencher or a fluor. Most commonly, the second reporter is
a quencher, and the energy from the first reporter is absorbed but re-emitted as heat
rather than light. The progress of the reaction can be monitored as the change in
fluorescence of the energy donor. During the exponential phase of PCR, the change in
fluorescence is proportional to the accumulation of PCR product. To simplify
quantitation, specially designed instruments perform both the thermal cycling steps to
amplify the target and fluorescence detection steps to measure the change in
fluorescence in real time.
More information about quantitative real-time
PCR...
One quantitative PCR (qPCR) approach employs hydrolysis probes that are complementary
to the accumulating PCR product and are labeled with a fluor at the 5′-end and a
quencher at the 3′-end. Because the two reporters are in close proximity, the
fluorescent signal is quenched. During the annealing step, the probe hybridizes to PCR
product generated in previous amplification cycles. The resulting probe:target hybrid is
a substrate for the 5′→3′ exonuclease activity of the DNA polymerase,
which degrades the annealed probe and liberates the fluor (Holland et
al. 1991). The fluor is freed from the effects of the energy-absorbing
quencher, and the progress of the reaction and accumulation of PCR product is monitored
by the resulting increase in fluorescence.
The Plexor® HY System takes a different approach, one that
does not require a hydrolysis probe, to determine the concentration of total human DNA
and male human DNA simultaneously in one reaction. This qPCR system takes advantage of
two novel bases, isoguanine (iso-G) and 5′-methylisocytosine (iso-C), which form a
unique base pair in double-stranded DNA. Amplification of each target uses two primers:
one primer is synthesized with an iso-C residue as the 5′-terminal nucleotide and a
fluorescent label at the 5′-end; the second primer is unlabeled. The reaction contains a
fluorescent quencher covalently linked to iso-G. As amplification proceeds, fluorescence
is reduced by site-specific incorporation of the fluorescent quencher opposite the iso-C
and in close proximity to the fluorescent dye located on the end of the primer.
By measuring the reduction in signal during each PCR cycle, an amplification curve is
generated. An amplification threshold is set within the exponential phase of PCR at a
fluorescence level where all amplification curves exhibit the most significant signal
decrease. To calculate the DNA concentration of an unknown sample, the cycle threshold
(CT), the point at which the amplification curve crosses the
amplification threshold, is determined and compared to a standard curve. The standard
curve is generated by determining the CT values for a dilution
series of a sample of known DNA quantity and plotting the log concentration on the X
axis and cycle threshold on the Y axis. After amplification, a melt analysis can be
performed to confirm that the correct product was amplified and expedite
troubleshooting, if necessary. The kit contains an internal PCR control (IPC) to test
for false-negative results that may occur in the presence of PCR inhibitors.
The Plexor® HY System is a sensitive multiplex kit that
routinely detects approximately 6.4pg of total DNA. PCR setup is performed at room
temperature and is compatible with automated platforms. The
Plexor® HY System is optimized for use on the Applied
Biosystems 7500 and 7500 FAST real-time PCR systems and Stratagene
Mx3005P® and Mx3000P® qPCR
systems. Protocols also exist for other qPCR instrumentation. These real-time PCR
instruments are not designed to interpret a decrease in fluorescence, so specific
software is required to make sense of raw Plexor® HY data.
The Plexor® Analysis Software interprets these data and
allows you to quickly and easily review data and create reports. Replicate samples are
automatically averaged, template amounts are calculated and the necessary volume of DNA
is displayed for your optimized STR amplification conditions in the Forensic Report. The
forensic release of the Plexor® Analysis Software is
available for free download.
Additional Resources for DNA Quantitation
Technical Bulletins and Manuals
TM293, TM294, TM296, TM299
Plexor® HY System Technical Manuals
EP037
Automated Plexor® HY System Setup for the
Biomek® 3000
Promega Publications
GIN024
The Plexor® HY System: Not solely a quantitation
technique
GIN023
The hidden benefits of real-time PCR: Assessing and addressing qualitative
challenges
GIN020
The Plexor™ Analysis Software
GIN019
Development of a novel, fluorescent, two-primer approach to quantitative
PCR
AN157
Developmental validation of a real-time PCR assay for the simultaneous
quantification of total human and male DNA
GE295
Validation Guide for the Plexor® HY
System
return to top of page
STR loci are amplified using fluorescently labeled PCR primers that flank the
hypervariable regions. One of the biggest strengths of PCR-based DNA typing is the
degree to which DNA can be amplified. Starting with a single DNA molecule, millions
or billions of DNA molecules can be synthesized after 32 cycles of amplification.
This level of sensitivity allows scientists to extract and amplify DNA from minute or
damaged samples and obtain useful DNA profiles.
STR amplification systems can accommodate a range of template DNA concentrations.
Most of the Promega PowerPlex® STR systems provide optimal
sister allele balance and locus-to-locus balance with 0.5–1.0ng of DNA template, and
studies performed at Promega show that full profiles can be observed with less than
100pg (Ensenberger and Fulmer, 2009; McLaren, 2007; Krenke et
al. 2005; Krenke et al. 2002). However, amplification
and detection instrumentation can vary. You may need to optimize protocols, including
cycle number and detection conditions (e.g., injection time or loading volume), for
each laboratory instrument. Most of the PowerPlex® systems
use a thermal cycling program with 30 or 32 cycles for 0.5–1ng of purified DNA
template. For larger amounts of input DNA (i.e., FTA®
paper) or to decrease sensitivity, fewer cycles should be evaluated. In-house
validation should be performed to determine the optimal amplification and detection
conditions.
The sensitive nature of PCR works in a lab's favor, but it can cause problems if
great care is not taken to avoid contaminating the reaction with exogenous DNA. Three
main categories of exogenous DNA have the biggest impact on DNA-typing laboratories:
1) DNA from the analyst, 2) DNA from other samples in the lab and 3) allelic ladder
fragments. DNA from nonhuman sources, such as bacteria and fungi, will not be
amplified and detected because STR systems are species-specific. Extreme care must be
taken to avoid cross-contamination when preparing sample DNA, handling primer pairs,
assembling amplification reactions and analyzing amplification products. Reagents and
materials used prior to amplification should be stored separately from those used
following amplification. Amplification reactions should be assembled in a room
dedicated for reaction setup, using equipment and supplies reserved for amplification
setup. We highly recommend the use of gloves and aerosol-resistant pipette tips. To
detect reagent contamination, assemble a negative control reaction (i.e., no
template) for every set of reactions, and scrutinize the reactions for the presence
of unexpected peaks. After setting up reactions, wash all surfaces with a dilute
bleach solution.
After assembly, reactions are subjected to thermal cycling, and PCR products are
separated by size using specialized polyacrylamide gel electrophoresis or capillary
electrophoresis (CE) instruments. During electrophoresis, DNA molecules move through
a polymer matrix in response to an electric field. The rate of migration depends on
fragment size, with smaller DNA fragments migrating more quickly through the porous
matrix than larger fragments. The instruments use a laser near the anode of the
capillary or polyacrylamide gel to excite and detect the fluorescent PCR products,
which appear as peaks on the resulting electropherogram (Figure 14.2). Each fluor is
detected in a separate dye channel. To reduce background, spectral calibration must
be performed to correct spectral overlap of dyes.
Size separation of amplification products in parallel with separation of an
allelic ladder, which consists of all major alleles at a particular locus, allows
positive identification of each allele that makes up the DNA profile. An internal
size standard is included in each analysis to control for run-to-run variation in
migration.
More
information about the background theory and principles of capillary
electrophoresis...
Figure 14.2. Representative PowerPlex® 16 HS System data.
A single template DNA (0.5ng) was amplified using the
PowerPlex® 16 HS 10X Primer Pair Mix.
Amplification products were mixed with Internal Lane Standard 600 and
analyzed with an Applied Biosystems 3130 Genetic Analyzer using a 3kV,
5-second injection. Results were analyzed using GeneMapper®
ID software, version 3.2. Panel A. An
electropherogram showing the peaks of the fluorescein-labeled loci: D3S1358,
TH01, D21S11, D18S51 and Penta E. Panel B. An electropherogram
showing the peaks of the JOE-labeled loci: D5S818, D13S317, D7S820, D16S539,
CSF1PO and Penta D. Panel C. An electropherogram showing the
peaks of the TMR-labeled loci: Amelogenin, vWA, D8S1179, TPOX and FGA.
Panel D. An electropherogram showing the 60bp to 500bp
fragments of the Internal Lane Standard 600.
Specialized allele-calling software eliminates the need for visual comparisons to
assign alleles, making the process faster, easier and more accurate. However, the
software does not address data quality, making a review of each sample necessary to
judge data quality and detect DNA mixtures or contamination. These reviews can be
performed manually by DNA analysts, but this is often tedious and time-consuming. In
many laboratories, data review has become the bottleneck for STR analysis now that
other DNA-typing steps are being automated. This has resulted in an increased
interest in expert system software. Expert systems for DNA-typing laboratories are
defined as systems that increase the efficiency or effectiveness of genotyping
samples by automatically interpreting STR data. An expert system can provide a second
set of independent allele calls and allow the analyst to skip the review of sample
data that the software has judged to be of high quality and focus on problematic
samples. Expert systems can objectively evaluate DNA mixtures in seconds and present
an analyst with the best-fit combinations of DNA profiles. Expert systems also can
compare all alleles called in a sample to the alleles in every other sample in the
batch and flag potential contamination events. Finally the software can summarize the
data and generate reports that contain only the necessary information.
Once a DNA profile is generated, statistical analysis is performed to determine if
the profile matches, with a reasonable degree of scientific certainty, that of a
known reference sample. The analyses performed depend on the type of STR locus.
Autosomal STR analysis employs the product rule, which calculates the probability
of finding a specific DNA profile within a population by multiplying the frequencies
of the alleles at each STR locus analyzed. This probability represents the number of
randomly selected individuals that theoretically must be surveyed before finding the
same DNA pattern in a population. To use the product rule, the STR loci must be
unlinked.
Autosomal STR analysis has a high statistical power of discrimination. For
example, when analyzing the 15 STR loci amplified by the
PowerPlex® 16 System, the power of discrimination is as
high as 1 in 1.42 × 1018 for some ethnic groups; this
exceeds the current global human population, making it unlikely that two DNA profiles
will match at random.
Statistical analysis can be used to determine if two individuals are related, as
is done for paternity testing and in missing persons investigations where a reference
sample from the missing person is not available but reference samples from close
relatives exist. For paternity testing, the paternity index is calculated to estimate
how many more times likely it is that the person being tested is the biological
father, rather than a randomly selected individual. The typical paternity index is
assigned to a locus rather than an individual case. The
PItypical of several loci is the product of the individual
PItypical values. Generally, a
PItypical of less than one is indicative of nonrelatedness.
The PItypical is represented by the following equation:
PItypical = X/Y
where X represents the chance that the alleged father transmitted the allele to
the child and Y represents the chance that some other man transmitted the allele.
For more information about statistical analysis of DNA testing results, refer to
Forensic DNA Typing (Butler, 2005).
Y-STR loci used in forensic and paternity applications are located in the
nonrecombining region of the human Y chromosome (NRY) and are faithfully transmitted
from father to son, unchanged except for rare mutations. Because Y-STR loci are not
inherited independently, statistical analysis cannot proceed by the product rule.
Instead, the frequency of a particular Y-STR profile (haplotype) is estimated by the
counting method, which is based on the frequency of a specific haplotype in a
population. To be useful, Y-STR databases must include thousands of Y-STR haplotypes,
enough that a sufficient number of haplotypes is represented and a meaningful
estimate of the frequency of a specific haplotype can be made. Several online
databases are available to assess Y-STR haplotype frequency:
U.S. Y-STR database
Y-HRD database
Additional Resources for STR Analysis
Technical Bulletins and Manuals
TMD028
PowerPlex® ESI 17 System Technical
Manual
TMD027
PowerPlex® ESI 16 System Technical
Manual
TMD024
PowerPlex® ESX 17 System Technical
Manual
TMD023
PowerPlex® ESX 16 System Technical
Manual
TMD022
PowerPlex® 16 HS System Technical
Manual
TMD021
PowerPlex® S5 System Technical Manual
TMD018
PowerPlex® Y System Technical Manual
TMD017
PowerPlex® ES System Technical Manual
TMD016
PowerPlex® 16 BIO System Technical
Manual
TMD012
PowerPlex® 16 System Technical Manual
TMD006
GenePrint® Fluorescent STR Systems Technical
Manual
Promega Publications
GIN027
The PowerPlex® 16 HS System.
GIN026
Bringing laser microdissection and on-chip PCR together.
GIN026
A solution for the split peak and n–10 artifacts at the vWA locus in
PowerPlex® 16 and
PowerPlex® ES Systems.
GIN026
Useful resources for your laboratory.
GIN024
An interview with Sir Alec Jeffreys.
GIN023
An introduction to PCR inhibitors.
GIN022
Debunking some urban legends surrounding validation within the forensic
DNA community.
GIN022
Nanotechnology and its potential in forensic DNA analysis.
GIN020
Identifying and preventing DNA contamination in a DNA-typing
laboratory.
GIN020
Using GeneMapper®
ID with Promega STR systems.
GIN018
Comparison of multiple STR platforms and instrumentation.
GIN017
The Penta BEC multiplex primers from Promega: Additional loci available
for identity testing.
GIN017
Tech Tips: The PowerPlex® Y System.
GIN016
Validation questions and answers.
GIN016
Troubleshooting capillary electrophoresis systems.
More articles
AN126
PowerPlex® 16 System validation.
return to top of page
In the past, law enforcement officers often limited the forensic casework samples
submitted for analysis to samples that had a good chance of producing a DNA profile.
More recently, realizing the sensitivity of STR analysis, officers are submitting more
trace samples with the hope that a DNA profile can be generated. Also, many law
enforcement agencies now are collecting database samples from an increasing number of
individuals such as arrestees in addition to convicted offenders. These factors increase
the number of samples that require processing. To keep pace with the increased workload,
many laboratories are automating key, potentially rate-limiting steps to increase
throughput. Such steps include differential extraction, DNA isolation, DNA quantitation
and normalization, and PCR setup.
Automation workstations vary in their capacities, from the low-throughput Biorobot
EZ1™ (Qiagen), which can purify DNA from up to six samples simultaneously in
approximately 20 minutes, and medium-throughput Maxwell® 16
Instrument (Cat.# AS3060), which can process up to 16
samples simultaneously in the same amount of time, to high-throughput workstations, such
as the Beckman Coulter Biomek® laboratory automation
workstations and Tecan Freedom EVO® liquid handlers, which
can process up to 96 samples simultaneously in as little as 40 minutes.
The Maxwell® 16 Instrument is a
magnetic-particle-handling device designed for low- to medium-throughput automated
DNA purification from a wide range of sample types. Unlike liquid handlers, which
move samples and reagents to the purification medium, magnetic-particle handlers move
the purification medium through each step in the purification process. Using magnets
to move the purification medium eliminates issues with clogged tips and incomplete
liquid transfers. The instrument is preprogrammed with purification protocols and
uses prefilled reagent cartridges, maximizing simplicity and convenience. The
instrument processes up to 16 samples per instrument run. There are two
configurations of the Maxwell® 16 Instrument. The SEV
(standard-elution volume) system elutes DNA in 300µl of elution buffer and is
suitable for DNA isolation from reference samples. The LEV (low-elution volume)
system can elute DNA in 25–50µl of elution buffer and is suitable for forensic
casework samples.
The DNA IQ™ Reference Sample Kit for Maxwell® 16
(Cat.# AS1040) allows DNA extraction from buccal
swabs, FTA® blood card punches, liquid blood or other DNA
reference samples using the Maxwell® 16 SEV Instrument.
The kit contains the trusted DNA IQ™ System reagents and is optimized to yield a
final DNA concentration that minimizes the need for concentration or dilution prior
to amplification. Liquid samples are placed directly into the cartridges, while
samples on solid supports require a preprocessing step in DNA IQ™ Lysis Buffer and
removal of the solid support before the samples are placed into the cartridges.
High-quality genomic DNA is obtained in approximately 20 minutes, at a concentration
suitable for direct use in STR analysis.
The DNA IQ™ Casework Pro Kit for Maxwell® 16
(Cat.# AS1240) allows DNA extraction from forensic
casework samples, including blood stains, semen stains, hairs, cigarette butts,
tissue samples, and trace or "touch" DNA samples regularly encountered in forensic
DNA analysis. The kit contains the DNA IQ™ reagents and uses the
Maxwell® 16 LEV Instrument with plastic cartridges and
plungers that allow DNA elution in a final volume of up to 50µl, providing a final
DNA extract in a concentrated format.
There are many robotic platforms that can dispense reagents, aspirate liquids and
perform manipulations of multiwell plates, including the Beckman Coulter
Biomek® laboratory automation workstations and Tecan
Freedom EVO® automated liquid-handlers. These
high-throughput instruments are significantly larger and more expensive than low- and
medium-throughput instruments. They also are complex to use and require detailed
knowledge of how the instrument operates, but their increased flexibility makes them
adaptable to a greater variety of tasks in the laboratory.
The Biomek® workstations use multichannel tools to
pipet volumes from 1µl to 1ml with high precision. Disposable pipette tips address
concerns about contamination during liquid-transfer steps. Beckman Coulter offers a
range of instruments, including the Biomek® 3000,
Biomek® NXP and Biomek® FXP,
with a range of options, capabilities, throughput levels and price points for
laboratories looking to automate their processes. With single-channel and
eight-channel pipetting, plate-moving capabilities, sample-tracking functionalities
and a rich programming language, the Biomek® 3000 is the
lowest cost option of these three instruments. Both the
Biomek® NXP and FXP workstations offer independent
eight-channel pipetting and gripping capabilities as well as flexible instrument
configuration. The Biomek® NXP represents an intermediate
cost and throughput level; the Biomek® FXP platform adds a
96-well pipetting head to the capabilities of the Biomek®
NXP. With increased size and pipetting capabilities, the
Biomek® FXP offers the highest flexibility and throughput
of the Beckman Coulter workstations.
The Tecan Freedom EVO® automated liquid-handler boasts
independent liquid-handling and gripping arms, adjustable tip spacing, independent
volume control on each tip and disposable-tip volumes of up to one milliliter. In
addition, the Freedom EVO® supports multiple deck sizes
and tip configurations, from a lower cost, 4-tip format to a higher throughput, 8-tip
instrument.
Promega has developed methods for these instruments to automate several steps of
the DNA-typing process, including differential extraction, DNA purification using the
DNA IQ™ System, DNA quantitation, DNA normalization and PCR setup.
Magnetic beads, such as the silica-coated DNA IQ™ Resin, can be used to separate
DNA from cellular debris and are ideally suited to automation. In addition to the
standard pipetting tools, robotic workstations can be equipped with a magnet, shaking
platform and thermal exchange unit to perform DNA-binding steps, washes and heated
elution. DNA can be isolated from both database and casework samples without
detectable cross-contamination using the DNA IQ™ System in combination with the
Biomek® or Freedom EVO®
workstation. Database samples that have been automated successfully include buccal
swabs, blood punches (FTA® and S&S 903) and liquid
blood; casework samples include sperm and epithelial fractions from differential
extractions, tissue samples, hairs and blood spots on blue jeans and underwear, among
others.
The Biomek® 2000 and 3000 instruments enable the user
to purify DNA from 8 to 96 samples (in increments of 8) from either “aqueous” or
“lysis” samples. Aqueous sample types are typically those that are preprocessed by
incubating with proteinase K prior to extraction, whereas lysis samples are
preprocessed by incubating in DNA IQ™ Lysis Buffer. For the
Biomek® 2000, different methods were developed for
different numbers of samples being processed (i.e., one method for 8 samples, one for
16, etc.) as well as for each sample type. The net result is that 24 methods exist
for 8 to 96 aqueous or lysis samples. For the Biomek® 3000
this number is reduced to one method. This single method allows the user to choose
between aqueous and lysis sample types and designate the number of samples being
processed. Promega also has developed and optimized scripts for DNA isolation on the
4-tip and 8-tip Freedom EVO® instruments using the DNA IQ™
System. These scripts are able to process 1–96 aqueous samples and lysis samples.
Additional Resources for Automated DNA Purification
Technical Bulletins and Manuals
TB347
DNA IQ™ Reference Sample Kit for Maxwell® 16
Technical Bulletin
TM332
DNA IQ™ Casework Pro Kit for Maxwell® 16
Technical Bulletin
Promega Publications
GIN026
The Maxwell® 16 Low Elution Volume System for
forensic casework: Implementation and routine use in a forensic
laboratory.
GIN025
DNA extraction using the Tecan Freedom EVO®
200 and DNA IQ™ System.
GIN025
The Maxwell® 16 applications
database.
GIN022
Automation in a forensic laboratory: An update.
GIN021
Forensic application of the Maxwell™ 16 Instrument.
GIN021
The DNA IQ™ System on the Tecan Freedom EVO®
100
GIN021
Automating the DNA IQ™ System on the Biomek®
3000 laboratory automation workstation
AN102
Extraction and isolation of DNA from blood cards and buccal swabs in a
96-well format
GE181
Validation Guide for the DNA IQ™ Reference Sample Kit for
Maxwell® 16.
GE621
Validation Guide for the DNA IQ™ Casework Pro Kit for
Maxwell® 16.
The Automated Differex™ System allows high-throughput, automated differential
extraction of sexual assault samples and integrates with the DNA IQ™ System for
subsequent DNA purification. Up to 48 samples can be processed in less than 5 hours
using the automated Differex™ protocol; 40 samples can be processed if wells are
reserved for DNA standards in downstream DNA quantitation. Two independent, but
related, automated methods are used to process differential extractions: the
automated Differex™ method and automated DNA IQ™ for Differex™ method. The automated
Differex™ method involves separating samples into epithelial and sperm fractions,
while the automated DNA IQ™ for Differex™ method purifies genomic DNA from each
fraction. The protocol begins with a proteinase K digestion of swab samples in a
Slicprep™ 96 Device, followed by centrifugation to pellet the sperm and separate
digestion products from the solid support material. The plate containing the sperm
pellets and supernatants is placed onto the deck of a robotic workstation, and the
automated Differex™ method begins. Automated Differex™ protocols exist for the
Biomek® 2000 and Biomek®
3000 workstations and Tecan Freedom EVO® 100
liquid handler.
The automated Differex™ method combines the Differex™ System reagents and DNA IQ™
Resin in a novel pellet-capping process. First, the robot dispenses DNA IQ™ Resin
directly on top of each sperm pellet. Upon application of a magnetic field, the
paramagnetic resin particles form a capping layer, which allows supernatant
manipulation without pellet disruption (Figure 14.3). A portion of the supernatant is
removed from each sample well and moved to an adjacent well for downstream processing
as the epithelial fraction. The remaining supernatant is removed from the pellet and
discarded or, if desired, archived. The resin-capped sperm pellets are washed four
times to dilute and remove any residual epithelial DNA-containing supernatant. During
the third wash, the resin-capped sperm pellets are resuspended to release any trapped
epithelial material. Resuspending the pellets requires a manual step to centrifuge
the sample plate and pellet the sperm. Following this centrifugation the robot adds a
second aliquot of DNA IQ™ Resin to re-establish the pellet cap. The Differex™
Separation Solution is used to float the epithelial DNA-containing wash buffer away
from the capped pellet to further improve epithelial DNA removal. The fourth and
final wash is performed to complete the automated Differex™ extraction. The sperm and
epithelial fractions then undergo automated DNA isolation using the DNA IQ™ System.
Integration of DNA IQ™ and Differex™ System components results in higher sperm
fraction yields and reproducible, automated sexual assault sample processing.
Additional Resources for Automated Differex™ System
Technical Bulletins and Manuals
EP030
Automated Differex™ System Protocol for the Tecan Freedom
EVO® System
EP031
Automated Differex™ System Protocol for the Beckman Coulter
Biomek® 2000
EP032
Automated Differex™ System Protocol for the Beckman Coulter
Biomek® 3000
Promega Publications
GIN024
Automating the Differex™ System.
Promega has worked in conjunction with Beckman Coulter to develop a tool for DNA
normalization and PCR setup on the Biomek® 2000
workstation. The Genetic Identity version of the Normalization Wizard, available from
Beckman Coulter, dilutes DNA samples at different concentrations to the desired final
concentration, then assembles the amplification reactions. The robot transfers PCR
master mix to strip tubes or plates, then adds a fixed volume of the normalized DNA.
The samples are capped manually and placed directly in a thermal cycler for
amplification.
Additional Resources for DNA Normalization and PCR Setp
Promega Publications
GIN018
Automated DNA normalization and STR multiplex setup methods.
return to top of page
- Anderson, S. et al.
(1981) Sequence and organization of the human mitochondrial genome.
Nature
290, 457–65.
- Budowle, B. et al.
(1991) Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE.
Am. J. Hum. Genet.
48, 137–44.
- Butler, J.M. (2005)
Forensic DNA Typing, Elsevier Academic Press, Burlington,
MA.
- Edwards, A. et al.
(1991a) DNA typing with trimeric and tetrameric tandem repeats: Polymorphic loci,
detection systems, and population genetics.
The Second International Symposium on Human Identification 1991, Promega
Corporation , 31–52.
- Edwards, A. et al.
(1991b) DNA typing and genetic mapping with trimeric and tetrameric tandem repeats.
Am. J. Hum. Genet.
49, 746–56.
- Edwards, A. et al.
(1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four
human population groups.
Genomics
12, 241–53.
- Ensenberger, M.G. and Fulmer, P.M. (2009) The PowerPlex® 16 HS System.
Profiles in DNA
12(1), 9–11.
- Gill, P. (2001) An assessment of the utility of single nucleotide polymorphisms (SNPs) for
forensic purposes.
Int. J. Leg. Med.
114, 204–10.
- Gill, P., Jeffreys, A.J. and Werrett, D.J. (1985) Forensic application of DNA ‘fingerprints’.
Nature
318, 577–9.
- Gusmão, L. and Carracedo, A. (2003) Y chromosome-specific STRs.
Profiles in DNA
6(1), 3–5.
- Holland, P.M. et al. (1991) Detection of specific polymerase chain reaction product by utilizing the
5′→3′ exonuclease activity of Thermus
aquaticus DNA polymerase.
Proc. Natl. Acad. Sci. USA
88, 7276–80.
- Jeffreys, A.J., Wilson, V. and Thein, S.L. (1985a) Hypervariable 'minisatellite' regions in human DNA.
Nature
314, 67–73.
- Jeffreys, A.J., Wilson, V. and Thein, S.L. (1985b) Individual-specific 'fingerprints' of human DNA.
Nature
316, 76–9.
- Krenke, B.E. et al.
(2002) Validation of a 16-locus fluorescent multiplex system.
J. Forensic Sci.
47, 773–85.
- Krenke, B.E. et al.
(2005) Validation of a male-specific, 12-locus fluorescent short tandem repeat (STR)
multiplex.
Forensic Sci. Int.
148, 1–14.
- Linch, C.A., Smith, S.L. and Prahlow, J.A. (1998) Evaluation of the human hair root for DNA typing subsequent to microscopic
comparison.
J. Forensic Sci.
43, 305–14.
- McLaren, R. (2007) PowerPlex® 16 versus
Identifiler® Systems: Sensitivity and effects of
inhibitors.
Application Notes 156 , Promega Corporation.
- Nakamura, Y. et al.
(1987) Variable number of tandem repeat (VNTR) markers for human gene mapping.
Science
235, 1616–22.
- Phillips, C. et al.
(2003) Selecting single nucleotide polymorphisms for forensic applications.
Int. Congr. Ser.
1261, 18–20.
- Saiki, R. et al.
(1985) Enzymatic amplification of beta-globin genomic sequences and restriction site
analysis for diagnosis of sickle cell anemia.
Science
230, 1350–4.
- Tereba, A. et al.
(2004) A new, rapid method to separate sperm and epithelial cells.
Profiles in DNA
7(2), 8–10.
- Tillmar, A.O. et al.
(2008) Analysis of linkage and linkage disequilibrium for eight X-STR markers.
For. Sci. Int. Genet.
3, 37–41.
- Warne, D. et al.
(1991) Tetranucleotide repeat polymorphism at the human ß-actin related pseudogene 2
(actbp2) detected using the polymerase chain reaction.
Nucleic Acid Res.
19, 6980.
- Wyman, A.R. and White, R. (1980) A highly polymorphic locus in human DNA.
Proc. Natl. Acad. Sci. USA
77, 6754–8.
return to top of page
STR loci are the subject of U.S. Pat. No. RE 37,984, German Pat. No. DE 38 34 636
C2 and other patents issued to the Max-Planck-Gesellschaft zur Förderung der
Wissenschaften, e.V., Germany. The development and use of STR loci are covered by
U.S. Pat. No. 5,364,759, Australian Pat. No. 670231 and other pending patents
assigned to Baylor College of Medicine, Houston, Texas. Patents for the foundational
PCR process, European Pat. Nos. 201,184 and 200,362, expired on March 28, 2006. In
the U.S., the patents covering the foundational PCR process expired on March 29,
2005.
The purchase of this product does not convey a license to use AmpliTaq
Gold® DNA polymerase. You should purchase AmpliTaq
Gold® DNA polymerase licensed for the forensic and
human identity field directly from your authorized enzyme supplier.
U.S. Pat. Nos. 6,238,863 and 6,767,703, Korean Pat. No. 691195 and other patents
pending.
U.S. Pat. Nos. 5,843,660, 6,479,235, 6,221,598 and 7,008,771, Australian Pat. No.
724531, Canadian Pat. No. 2,118,048, Korean Pat. No. 290332, Singapore Pat. No.
57050, Japanese Pat. No. 3602142, Chinese Pat. No. 10366753, European Pat. No.
0960207 and other patents pending.
Allele sequences for one or more of the loci vWA, FGA, D8S1179, D21S11 and D18S51
in allelic ladder mixtures is licensed under U.S. Pat. No. 7,087,380, Australia Pat.
No. 2003200444 and corresponding patent claims outside the US.
Products may be covered by pending or issued patents or may have certain limitations. Please visit our web
site for more information.
All prices and specifications are subject to change without
prior notice.
Product claims are subject to change. Please contact
Promega Technical Services or access the Promega online catalog for the
most up-to-date information on Promega products.